<DOC>
	<DOC>NCT00479388</DOC>
	<brief_summary>This is a 12-Week clinical trial in patients with Primary hypercholesterolemia or mixed dyslipidemia to study the effects of ER niacin/laropiprant on lipids.</brief_summary>
	<brief_title>Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Patients 18 to 80 years of age with Primary hypercholesterolemia or mixed dyslipidemia Patients will be eligible for the study if their LDLC values are within protocol specified range and meet other entry criteria Patient whose LDLC values are not within protocol specified range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>